Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Nu-3 Gel for Infected Diabetic Foot Ulcers
Phase 2
Not yet recruiting
- Conditions
- Diabetic Foot Infection
- Interventions
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Lakewood-Amedex Inc
- Target Recruit Count
- 60
- Registration Number
- NCT06020235
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
Phase 2
Terminated
- Conditions
- Chronic Diabetic Foot Ulcers
- Interventions
- Drug: 5% Bisphosphocin Topical GelDrug: Placebo Topical GelDrug: 10% Bisphosphocin Topical Gel
- First Posted Date
- 2022-03-11
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Lakewood-Amedex Inc
- Target Recruit Count
- 3
- Registration Number
- NCT05276401
- Locations
- 🇺🇸
NEA Baptist Clinic, Jonesboro, Arkansas, United States
🇺🇸Limb Preservation Platform, Inc., Fresno, California, United States
🇺🇸Doctors Research Network, South Miami, Florida, United States
Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus
Phase 1
Completed
- Conditions
- Diabetic Foot Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-04-14
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- Lakewood-Amedex Inc
- Target Recruit Count
- 31
- Registration Number
- NCT02737722
- Locations
- 🇺🇸
Center for Clinical Research, Inc., San Francisco, California, United States
🇺🇸Journey Research, Inc., Oldsmar, Florida, United States
🇺🇸Clinical Research Solutions, Franklin, Tennessee, United States
News
No news found